[6]-Gingerol Suppresses Colon Cancer Growth by Targeting Leukotriene A4 Hydrolase

被引:148
作者
Jeong, Chul-Ho [1 ]
Bode, Ann M. [1 ]
Pugliese, Angelo [1 ]
Cho, Yong-Yeon [1 ]
Kim, Hong-Gyum [1 ]
Shim, Jung-Hyun [1 ]
Jeon, Young-Jin [1 ,2 ]
Li, Honglin [3 ,4 ]
Jiang, Hualiang [3 ,4 ]
Dong, Zigang [1 ]
机构
[1] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA
[2] Chosun Univ, Coll Med, Dept Pharmacol, Gwanju, South Korea
[3] Chinese Acad Sci, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai Inst Mat Med, Beijing 100864, Peoples R China
[4] E China Univ Sci & Technol, Sch Pharm, Shanghai 200237, Peoples R China
关键词
NF-KAPPA-B; INFLAMMATORY RESPONSES; IN-VIVO; INHIBITORS; MICE; CHEMOPREVENTION; EXPRESSION; BESTATIN; DOCKING; ENZYME;
D O I
10.1158/0008-5472.CAN-09-0491
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
[6]-Gingerol, a natural component of ginger, exhibits anti-inflammatory and antitumorigenic activities. Despite its potential efficacy in cancer, the mechanism by which [6]-gingerol exerts its chemopreventive effects remains elusive. The leukotriene A(4) hydrolase (LTA(4)H) protein is regarded as a relevant target for cancer therapy. Our in silico prediction using a reverse-docking approach revealed that LTA(4)H might be a potential target of [6]-gingerol. We supported our prediction by showing that [6]-gingerol suppresses anchorage-independent cancer cell growth by inhibiting LTA(4)H activity in HCT116 colorectal cancer cells. We showed that [6]-gingerol effectively suppressed tumor growth in vivo in nude mice, an effect that was mediated by inhibition of LTA(4)H activity. Collectively, these findings indicate a crucial role of LTA(4)H in cancer and also support the anticancer efficacy of [6]-gingerol targeting of LTA(4)H for the prevention of colorectal cancer. [Cancer Res 2009;69(13):5584-91]
引用
收藏
页码:5584 / 5591
页数:8
相关论文
共 35 条
[1]
Gingerol metabolite and a synthetic analogue Capsarol™ inhibit macrophage NF-κB-mediated iNOS gene expression and enzyme activity [J].
Aktan, Fugen ;
Henness, Sheridan ;
Tran, Van H. ;
Duke, Colin C. ;
Roufogalis, Basil D. ;
Ammit, Alaina J. .
PLANTA MEDICA, 2006, 72 (08) :727-734
[2]
Leukotriene A4 hydrolase:: a critical role of glutamic acid-296 for the binding of bestatin [J].
Andberg, M ;
Wetterholm, A ;
Medina, JF ;
Haeggström, JZ .
BIOCHEMICAL JOURNAL, 2000, 345 :621-625
[3]
Chemoprevention of colorectal cancer: Ready for routine use? [J].
Arber, N ;
Levin, B .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (05) :517-525
[4]
Leukotriene A4 hydrolase expression in PEL cells is regulated at the transcriptional level and leads to increased leukotriene B4 production [J].
Arguello, Mezti ;
Paz, Suzanne ;
Hernandez, Eduardo ;
Corriveau-Bourque, Catherine ;
Fawaz, Lama M. ;
Hiscott, John ;
Lin, Rongtuan .
JOURNAL OF IMMUNOLOGY, 2006, 176 (11) :7051-7061
[5]
Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions [J].
Avis, I ;
Hong, SH ;
Martínez, A ;
Moody, T ;
Choi, YH ;
Trepel, J ;
Das, R ;
Jett, M ;
Mulshine, JL .
FASEB JOURNAL, 2001, 15 (09) :2007-+
[6]
Bode AM, 2001, CANCER RES, V61, P850
[7]
The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells [J].
Bortuzzo, C ;
Hanif, R ;
Kashfi, K ;
StaianoCoico, L ;
Shiff, SJ ;
Rigas, B .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1300 (03) :240-246
[8]
Leukotriene A4 hydrolase as a target for cancer prevention and therapy [J].
Chen, X ;
Wang, S ;
Wu, N ;
Yang, CS .
CURRENT CANCER DRUG TARGETS, 2004, 4 (03) :267-283
[9]
Leukotriene A4 hydrolase in rat and human esophageal adenocarcinomas and inhibitory effects of bestatin [J].
Chen, XX ;
Li, N ;
Wang, S ;
Wu, N ;
Hong, JI ;
Jiao, XL ;
Krasna, MJ ;
Beer, DG ;
Yang, CS .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (14) :1053-1061
[10]
LEUKOTRIENE SYNTHESIS BY HUMAN GASTROINTESTINAL TISSUES [J].
DREYLING, KW ;
HOPPE, U ;
PESKAR, BA ;
MORGENROTH, K ;
KOZUSCHEK, W ;
PESKAR, BM .
BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 878 (02) :184-193